Surrey Heartlands

Joint Formulary & PAD

Eptinezumab - Migraine (prevention)

You are here : Home > Formulary Search > Eptinezumab - Migraine (prevention)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
NICE
Restrictions / Comments :

Documentation

Evidence Review
NICE TA871 Eptinezumab for preventing migraine Briefing paper Apr23.pdf
Webpage
Eptinezumab for preventing migraine TA871

PAD Profile

ChemicalSubstance :
Eptinezumab
Indication :
Migraine (prevention)
Group Name :
Keywords :
fully human IgG2 monoclonal antibody, anti-calcitonin gene-related peptides, CGRP, migraine prophylaxis, migraine prevention, episodic migraine, chronic migraine
Brand Names Include :
Vyepti
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Migraine (prevention)
Supporting Documents :
2

Other Indications

Below are listed other indications that Eptinezumab is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Migraine (prevention).

Committee Recommendations (1)

05 Apr 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee recommends eptinezumab as a treatment option for preventing migraine in line with NICE TA871. Eptinezumab will be given a RED traffic light status for this indication. Prescribing will be by hospital specialists only, in line with NICE TA871. Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication.